Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01025999 · ClinicalTrials.gov registry record
Mechanisms of Glycemic Improvement After Gastrointestinal Surgery
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 7
- Enrollment target
NCT01025999 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 7 participants.
The verdict
NCT01025999 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This study is designed as a prospective clinical trial aimed at investigating the mechanisms behind observed improvements in type 2 diabetes mellitus (T2DM) following bariatric surgery. The majority of patients with T2DM who are undergoing Roux-en-Y gastric bypass (RYGB) surgery, in particular, experience complete remission of T2DM almost immediately post-surgery. This response occurs before significant weight loss is possible. To assess the mechanisms involved with disease resolution, the investigators propose a study to evaluate patients at the UW Medical Center (UWMC) who have T2DM and are undergoing RYGB with G (gastronomy)-tube placement as part of their clinical care. The investigators are interested in this sub-population as the G-tube allows us the unique opportunity to evaluate glycemic control and insulin response following delivery or exclusion of nutrients to the otherwise bypassed portion of the gastrointestinal tract. The investigators hypothesize that nutrient delivery to the proximal GI tract will reverse RYGB-mediated improvements in glucose homeostasis, possibly in association with changes in nutrient-regulated gut peptides involved in glucose control.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01025999
The ClinicalTrials.gov registry entry for NCT01025999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT01025999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01025999 about?
NCT01025999 is a clinical study titled "Mechanisms of Glycemic Improvement After Gastrointestinal Surgery". This study is designed as a prospective clinical trial aimed at investigating the mechanisms behind observed improvements in type 2 diabetes mellitus (T2DM) following bariatric surgery. The majority of patients with T2DM who are undergoing Roux-en-Y gastric bypass (RYGB) surgery, in particular, expe...
What is the current status of trial NCT01025999?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2010-01. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01025999?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT01025999?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.